Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
8 September 2025
Gynecologic Cancer Awareness Month
September is “Gynecologic Cancer Awareness Month”, and various global activities are aiming to highlight and increase the awareness of gynecologic cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of gynecologic cancer, which were published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.
The list of relevant papers can be seen below:
“Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment”
by Holly Baker-Rand and Sarah J. Kitson
Cancers 2024, 16(5),1028; https://doi.org/10.3390/cancers16051028
Available online: https://www.mdpi.com/2072-6694/16/5/1028
“Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions”
by Rohan Kalyan Rej, Joyeeta Roy and Srinivasa Rao Allu
Cancers 2024, 16(3), 552; https://doi.org/10.3390/cancers16030552
Available online: https://www.mdpi.com/2072-6694/16/3/552
“Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer”
by Niraj Neupane, Sawyer Bawek, Sayuri Gurusinghe, Elham Moases Ghaffary, Omid Mirmosayyeb, Sangharsha Thapa, Carla Falkson, Ruth O’Regan and Ajay Dhakal
Cancers 2024, 16(3), 619; https://doi.org/10.3390/cancers16030619
Available online: https://www.mdpi.com/2072-6694/16/3/619
“Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer”
by Brittney S. Zimmerman and Francisco J. Esteva
Cancers 2024, 16(4), 800; https://doi.org/10.3390/cancers16040800
Available online: https://www.mdpi.com/2072-6694/16/4/800
“Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond”
by Virginia Valentini, Agostino Bucalo, Giulia Conti, Ludovica Celli, Virginia Porzio, Carlo Capalbo, Valentina Silvestri and Laura Ottini
Cancers 2024, 16(3), 579; https://doi.org/10.3390/cancers16030579
Available online: https://www.mdpi.com/2072-6694/16/3/579
“PARP Inhibitors: Strategic Use and Optimal Management in Ovarian Cancer”
by Nicholas Hirschl, Wildnese Leveque, Julia Granitto, Valia Sammarco, Mervyns Fontillas and Richard T. Penson
Cancers 2024, 16(5), 932; https://doi.org/10.3390/cancers16050932
Available online: https://www.mdpi.com/2072-6694/16/5/932
“Ensemble Deep Learning-Based Image Classification for Breast Cancer Subtype and Invasiveness Diagnosis from Whole Slide Image Histopathology”
by Aadhi Aadhavan Balasubramanian, Salah Mohammed Awad Al-Heejawi, Akarsh Singh, Anne Breggia, Bilal Ahmad, Robert Christman, Stephen T. Ryan and Saeed Amal
Cancers 2024, 16(12), 2222; https://doi.org/10.3390/cancers16122222
Available online: https://www.mdpi.com/2072-6694/16/12/2222
“Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis”
by Michela Roberto, Giacomo Barchiesi, Blerina Resuli, Monica Verrico, Iolanda Speranza, Leonardo Cristofani, Federica Pediconi, Federica Tomao, Andrea Botticelli and Daniele Santini
Cancers 2024, 16(3), 596; https://doi.org/10.3390/cancers16030596
Available online: https://www.mdpi.com/2072-6694/16/3/596
“Resistance to Targeted Inhibitors of the PI3K/AKT/mTOR Pathway in Advanced Oestrogen-Receptor-Positive Breast Cancer”
by Iseult M.Browne and Alicia F. C. Okines
Cancers 2024, 16(12), 2259; https://doi.org/10.3390/cancers16122259
Available online: https://www.mdpi.com/2072-6694/16/12/2259
“The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy”
by Corrado Tinterri, Bethania Fernandes, Alberto Zambelli, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Shadya Sara Darwish, Flavia Jacobs, Camilla De Carlo, Martina Iuzzolino et al.
Cancers 2024, 16(2), 376; https://doi.org/10.3390/cancers16020376
Available online: https://www.mdpi.com/2072-6694/16/2/376
You are welcome to submit relevant papers to the journal Cancers using the link below.
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
